Dalton Medicinal Chemistry Partners and Boehringer Ingelheim (Canada) Ltd. enter into a Medicinal Chemistry Agreement

27-Mar-2007

Dalton medicinal chemistry Partners, the Medicinal Chemistry arm of Dalton Pharma Services, announced the signing of a Medicinal Chemistry agreement with Boehringer Ingelheim (Canada) Ltd.

Dalton Medicinal Chemistry Partners will utilize their medicinal chemistry expertise to design and synthesize novel compounds against a number of antiviral targets selected by Boehringer Ingelheim (Canada) Ltd.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance